We are live on ! Find out more
VRDN icon

Viridian Therapeutics
VRDN

135 hedge funds and large institutions have $1.1B invested in Viridian Therapeutics in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

246% more call options, than puts

Call options by funds: $7.59M | Put options by funds: $2.19M

87% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 15

46% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 37

11% more funds holding

Funds holding: 122 → 135 (+13)

2.05% less ownership

Funds ownership: 102.45% → 100.39% (-2.1%)

9% less capital invested

Capital invested by funds: $1.21B → $1.1B (-$110M)

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

Holders
135
Holders Change
+13
Holders Change %
+10.66%
% of All Funds
2.15%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.11%
New
28
Increased
54
Reduced
37
Closed
15
Calls
$7.59M
Puts
$2.19M
Net Calls
+$5.4M
Net Calls Change
+$5.51M

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$36.2M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$33.4M
3
HRCM
Hood River Capital Management
Florida
+$18.2M
4
PCH
Polar Capital Holdings
United Kingdom
+$17.6M
5
State Street
State Street
Massachusetts
+$17.3M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$35.9M
2
BI
BVF Inc
California
-$34.3M
3
DTC
Deep Track Capital
Connecticut
-$17.3M
4
KCM
Kynam Capital Management
New Jersey
-$15.7M
5
TCM
TCG Crossover Management
California
-$10.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
76
Jane Street
New York
$1.1M +$1.38M +43,045 New
California State Teachers Retirement System (CalSTRS)
77
California State Teachers Retirement System (CalSTRS)
California
$1.04M -$13K -405 -1%
SEI Investments
78
SEI Investments
Pennsylvania
$950K +$590K +18,410 +97%
SCM
79
Silverarc Capital Management
Massachusetts
$926K +$1.07M +33,381 +1,113%
Renaissance Technologies
80
Renaissance Technologies
New York
$911K +$1.15M +35,800 New
AA
81
AlphaCentric Advisors
Puerto Rico
$903K – – –
CIP
82
Chartwell Investment Partners
Pennsylvania
$855K -$880K -27,453 -45%
PA
83
Profund Advisors
Maryland
$837K +$1.05M +32,900 New
State of Wisconsin Investment Board
84
State of Wisconsin Investment Board
Wisconsin
$802K +$47.9K +1,493 +5%
CS
85
Credit Suisse
Switzerland
$657K +$57.5K +1,794 +7%
Tudor Investment Corp
86
Tudor Investment Corp
Connecticut
$613K +$773K +24,110 New
UBS AM
87
UBS AM
Illinois
$601K +$133K +4,151 +21%
Mirae Asset Global Investments
88
Mirae Asset Global Investments
South Korea
$589K +$215K +6,702 +41%
SFI
89
Susquehanna Fundamental Investments
Pennsylvania
$579K – – –
T. Rowe Price Associates
90
T. Rowe Price Associates
Maryland
$577K -$71.7K -2,235 -9%
EGM
91
Engineers Gate Manager
New York
$534K +$412K +12,836 +158%
US Bancorp
92
US Bancorp
Minnesota
$521K +$297K +9,273 +83%
New York State Common Retirement Fund
93
New York State Common Retirement Fund
New York
$513K -$92.7K -2,892 -13%
LP
94
LMR Partners
United Kingdom
$509K -$962K -30,000 -60%
CA
95
Cetera Advisors
Colorado
$507K +$640K +19,945 New
MIM
96
MetLife Investment Management
New Jersey
$505K – – –
Invesco
97
Invesco
Georgia
$474K -$5.64M -175,887 -90%
AIG
98
American International Group
New York
$469K +$18K +561 +3%
Legal & General Group
99
Legal & General Group
United Kingdom
$406K +$122K +3,810 +31%
Manulife (Manufacturers Life Insurance)
100
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$383K +$19.5K +609 +4%
2 3
4
5 6

VRDN Hedge Fund Activity: Q1 2023 in Review

135 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Viridian Therapeutics (VRDN) for Q1 2023, worth a combined $1.1B — down 9.1% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new VRDN positions and 15 closed out — a net gain of 13 holders — while 54 added to existing stakes and 37 trimmed.

The largest buyer was RA Capital Management, adding an estimated $36.2M. The largest seller was Citadel Advisors, cutting an estimated $35.9M.

  • 135 institutional investors held Viridian Therapeutics (VRDN) as of Q1 2023, up from 122 in Q4 2022.
  • Funds reported $1.1B of Viridian Therapeutics stock for Q1 2023, down 9.1% quarter-over-quarter.
  • 28 funds opened new Viridian Therapeutics positions in Q1 2023 and 15 closed out, a net change of +13 holders.
  • The largest Viridian Therapeutics buyer in Q1 2023 was RA Capital Management, an estimated $36.2M added.
  • The largest Viridian Therapeutics seller in Q1 2023 was Citadel Advisors, an estimated $35.9M sold.

Based on aggregated 13F filings for Q1 2023.